Gene · 4299
Papers2,225
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,225
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| AFF4 globally affects the release of paused RNA polymerase II in HEL cells. | Yi Chuan | 2023 | 37609817 | PubTator, text mining | PubMed |
| Upregulation of S100A6 and its relation with CD34+ cells apoptosis in high-risk myelodysplastic syndromes patients. | Heliyon | 2023 | 37609402 | PubTator, text mining | PubMed |
| Shift of N-MYC Oncogene Expression in AML Patients Carrying the FLT3-ITD Mutation. | Pathophysiology | 2023 | 37606386 | PubTator, text mining | PubMed |
| Short-course blinatumomab for refractory/relapse precursor B acute lymphoblastic leukemia in children. | Front Pediatr | 2023 | 37601130 | PubTator, text mining | PubMed |
| A genome-wide association study of blood cell morphology identifies cellular proteins implicated in disease aetiology. | Nat Commun | 2023 | 37596262 | PubTator, text mining | PubMed |
| Exome sequencing identifies breast cancer susceptibility genes and defines the contribution of coding variants to breast cancer risk. | Nat Genet | 2023 | 37592023 | PubTator, text mining | PubMed |
| Realizing the AF4-UV-SAXS on-line coupling on protein and antibodies using high flux synchrotron radiation at the CoSAXS beamline, MAX IV. | Anal Bioanal Chem | 2023 | 37572213 | PubTator, text mining | PubMed |
| YY1 Knockdown Relieves the Differentiation Block and Restores Apoptosis in AML Cells. | Cancers (Basel) | 2023 | 37568827 | PubTator, text mining | PubMed |
| EPH/Ephrin Signaling in Normal Hematopoiesis and Hematologic Malignancies: Deciphering Their Intricate Role and Unraveling Possible New Therapeutic Targets. | Cancers (Basel) | 2023 | 37568780 | PubTator, text mining | PubMed |
| Histone acetylation by HBO1 (KAT7) activates Wnt/β-catenin signaling to promote leukemogenesis in B-cell acute lymphoblastic leukemia. | Cell Death Dis | 2023 | 37542030 | PubTator, text mining | PubMed |
| Dot1l cooperates with Npm1 to repress endogenous retrovirus MERVL in embryonic stem cells. | Nucleic Acids Res | 2023 | 37522386 | PubTator, text mining | PubMed |
| CircAFF1 Is a Circular RNA with a Role in Alveolar Rhabdomyosarcoma Cell Migration. | Biomedicines | 2023 | 37509532 | PubTator, text mining | PubMed |
| The Role of S100A6 in Human Diseases: Molecular Mechanisms and Therapeutic Potential. | Biomolecules | 2023 | 37509175 | PubTator, text mining | PubMed |
| Emotional brain network decoded by biological spiking neural network. | Front Neurosci | 2023 | 37496741 | PubTator, text mining | PubMed |
| Cuproptosis-related risk score based on machine learning algorithm predicts prognosis and characterizes tumor microenvironment in head and neck squamous carcinomas. | Sci Rep | 2023 | 37481622 | PubTator, text mining | PubMed |
| Activation of GPR44 decreases severity of myeloid leukemia via specific targeting of leukemia initiating stem cells. | Cell Rep | 2023 | 37459233 | PubTator, text mining | PubMed |
| miR-16-5p enhances sensitivity to RG7388 through targeting PPM1D expression (WIP1) in Childhood Acute Lymphoblastic Leukemia. | Cancer Drug Resist | 2023 | 37457129 | PubTator, text mining | PubMed |
| Tuning the Cross-Linking Density and Cross-Linker in Core Cross-Linked Polymeric Micelles and Its Effects on the Particle Stability in Human Blood Plasma and Mice. | Biomacromolecules | 2023 | 37449781 | PubTator, text mining | PubMed |
| Azacitidine and lenalidomide combination: a novel relapse prophylaxis regimen after allogeneic hematopoietic stem-cell transplantation in patients with acute myeloid leukemia. | Front Immunol | 2023 | 37435080 | PubTator, text mining | PubMed |
| Role of RNA methylation in the regulation of pancreatic cancer stem cells (Review). | Oncol Lett | 2023 | 37427348 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4299/papers?page=8